Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Australian Clinical Labs (ACL) is a leading private provider of pathology services in Australia, operating a national network of more than 70 laboratories and 1,300 collection centers. The company offers a comprehensive suite of diagnostic services, including routine pathology, molecular genetics, and veterinary pathology, serving over 90 public and private hospitals. ACL is distinguished by its unified national pathology system and its focus on scientific leadership and technological innovation in areas such as precision medicine and digital health. The company was formed in 2015 through the acquisition of Healthscope's pathology business and listed on the Australian Securities Exchange in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on clinical laboratories.